Stroke Rates Rising Among US Young Adults, yet 1 in 3 Don’t Know Common Symptoms
New research shows nearly 30% of US young adults do not know the 5 most common stroke symptoms, almost 3 million are not aware of any symptoms.
What do you Know about Weight Loss Medications?
Weight loss is essential to arrest the cardiovascular disease and metabolic dysfunction linked to obesity. What do you know about the drugs now available that may help?
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 27, 2020
How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.
Kidney Week: Dapagliflozin Renoprotective, Cardioprotective in CKD Patients
Dapagliflozin is renoprotective and cardioprotective in chronic kidney disease patients, suggests a secondary analysis of the DAPA-CKD trial presented at Kidney Week 2020.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 26, 2020
Confirmed cases of COVID-19 surged in these 5 states, global cases topped 43 million, and more COVID-19 data to know about today, October 26, 2020.
Low-dose Aspirin Reduces Risk of COVID-19 Mortality in Hospitalized Patients
Reduced risk of mortality as well as of ICU admission and mechanical ventilation were observed in patients with COVID-19 taking daily aspirin for CV prevention.
Remdesivir Becomes First FDA-approved Drug for COVID-19 Treatment
The FDA has approved remdesivir for the treatment of COVID-19, making it the first approved treatment for the novel disease.
Finerenone Slows Renal Decline, Improves CV Outcomes in FIDELIO-DKD
The investigational mineralocorticoid receptor antagonist slowed progression to renal failure by 18% and reduced the composite cardiovascular outcome by 14%, authors report.
Hospitalized COVID-19 Patients Have More, More Severe Complications vs Patients with Influenza
The first study to compare COVID-19 and influenza complications in hospitalized patients found COVID-19 patients more likely to be admitted to ICU and to die.
A COVID-19 “Misinfodemic”: 7 Questions on American Misperceptions
A recent survey assessed American’s acceptance of 11 false COVID-19 claims circulating online. What were the results? Take our 7-question quiz to find out.
Dangerous CV Drug-Drug Interactions: A 5-question Quiz
Cardiovascular medications are widely-prescribed in the US. Alex Evans, PharmD, MBA, drafted questions on the top 5 dangerous interactions he sees regularly in practice.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 23, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
NIH Updates Testing, Treatment Guidelines During Cocirculation of Influenza and COVID-19
The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 22, 2020
Global confirmed cases of COVID-19 have surpassed 41 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Two Studies Find COVID-19 Antibodies Can Persist for Months
New research shows COVID-19 survivors continue to produce protective antibodies against key parts of the virus for at least 3-4 months after developing symptoms.
Expert Update on Lp(a): Dr Patrick Moriarty Explains the Next CVD Target
Elevated lipoprotein A is a genetically determined independent risk factor for CVD, affecting up to 30% of the population. Phase 3 trials for the first treatment are underway.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 21, 2020
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 20, 2020
US confirmed cases of COVID-19 have surpassed 8 million; global cases have reached 40 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
ATS 2020: Masitinib Significantly Reduces Severe Asthma Exacerbations
New research presented at the American Thoracic Society virtual symposium showed the first-in-class drug reduced severe asthma exacerbation rate by 35% vs placebo.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of October 19, 2020
Global confirmed cases of COVID-19 have surpassed 40 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
